In view of the highly recurrent distal 2p gains in high-risk NBs this suggests that, in addition to increased expression levels of MYCN in cases of MYCN non-amplified tumors, an extra copy of the ALK gene and the gene for its ligand could impact tumor formation. The gene discussed is MYCN; the disease is neoplasm.